Vertex Pharmaceuticals, Inc.’s recently made public that its EVP and Chief Legal Officer Biller Jonathan unloaded Company’s shares for reported $0.46 million on Oct 02 ’24. In the deal valued at $461.66 per share,999 shares were sold. As a result of this transaction, Biller Jonathan now holds 16,651 shares worth roughly $8.02 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Biller Jonathan bought 999 shares, generating $461,198 in total proceeds.
Before that, LEIDEN JEFFREY M sold 3,784 shares. Vertex Pharmaceuticals, Inc. shares valued at $1,888,216 were divested by the Executive Chairman at a price of $499.00 per share. As a result of the transaction, LEIDEN JEFFREY M now holds 9,994 shares, worth roughly $4.81 million.
A number of analysts have revised their coverage, including Barclays’s analysts, who decreased its forecast for the stock in early August from “an Overweight” to “an Equal weight”. Redburn Atlantic began covering VRTX with “Buy” recommendation on June 27, 2024. Evercore ISI revised its rating on April 11, 2024. It rated VRTX as “an Outperform” which previously was an “an In-line”.
Price Performance Review of VRTX
On Friday, Vertex Pharmaceuticals, Inc. [NASDAQ:VRTX] saw its stock jump 1.17% to $481.71. Over the last five days, the stock has gained 5.80%. Vertex Pharmaceuticals, Inc. shares have risen nearly 18.39% since the year began. Nevertheless, the stocks have risen 31.89% over the past one year. While a 52-week high of $510.64 was reached on 08/01/24, a 52-week low of $341.90 was recorded on 04/18/24. SMA at 50 days reached $473.45, while 200 days put it at $446.37.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 477.42, which if violated will result in even more drops to 473.14. On the upside, there is a resistance level at 484.44. A further resistance level may holdings at 487.18. The Relative Strength Index (RSI) on the 14-day chart is 58.69, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 11.71, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.35%. Stochastics %K at 89.40% indicates the stock is a selling.
How much short interest is there in Vertex Pharmaceuticals, Inc.?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc. stocks on 2024-09-30, dropping by -0.3 million shares to a total of 4.08 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 4.38 million shares. There was a decline of -7.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 15, 2024 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $515 price target.
